LISA IVY: Open Payments
NPI 1033103296 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 9 payments from 6 companies in 2025. Trend: 2023 $203 · 2024 $186 · 2025 $142
Food & beverage: $142
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Wegovy, VERQUVO, LEQVIO, FARXIGA, FUROSCIX, JARDIANCE.
Industry payments across AR — which companies pay providers there.
